Toma L, Berninsone P, Hirschberg C B
Department of Molecular and Cell Biology, Boston University Goldman School of Dental Medicine, Boston, Massachusetts 02118, USA.
J Biol Chem. 1998 Aug 28;273(35):22458-65. doi: 10.1074/jbc.273.35.22458.
N-Deacetylation and N-sulfation of N-acetylglucosamine of heparin and heparan sulfate are hypothesized to be mediated by different tissue-specific N-acetylglucosaminyl N-deacetylases/N-sulfotransferases, which in turn lead to the higher L-iduronic acid and sulfate content of heparin versus heparan sulfate. Furthermore, the putative heparin-specific N-acetylglucosaminyl N-deacetylase/N-sulfotransferase has been reported to require auxiliary proteins for its N-acetylglucosaminyl N-deacetylase activity in vivo based on its requirement of polycations in vitro. We have now found that cells derived from embryonic bovine trachea, a tissue that does not synthesize heparin, has a N-acetylglucosaminyl N-deacetylase/N-sulfotransferase, which has 95% amino acid sequence identity to the above enzyme postulated to be involved in the biosynthesis of heparin. Both enzymes also have very similar affinity for their substrates. The trachea enzyme does not require additional effectors for its N-acetylglucosaminyl N-deacetylase activity in vitro even though its biochemical characteristics are virtually the same as the enzyme previously isolated from cells of a heparin-producing mastocytoma tumor. The trachea enzyme, which is encoded by an abundant 4.6-kilobase mRNA, like mastocytoma cells, has 70% amino acid sequence identity with the corresponding enzyme from rat liver postulated to participate in the biosynthesis of heparan sulfate. Heparan sulfate synthesized by trachea cells has a higher content of sulfated iduronic acid than from other tissues. Together, the above results strongly suggest that the above enzymes from mastocytoma, liver, and trachea, per se, are not solely responsible for the selective tissue-specific synthesis of heparin or heparan sulfate; more likely cellular factors, additional enzymes, and availability of substrates in the Golgi lumen also play important roles in the differential synthesis of the above proteoglycans.
据推测,肝素和硫酸乙酰肝素中N - 乙酰葡糖胺的N - 脱乙酰化和N - 硫酸化是由不同的组织特异性N - 乙酰葡糖胺N - 脱乙酰酶/N - 硫酸转移酶介导的,这进而导致肝素相对于硫酸乙酰肝素具有更高的L - 艾杜糖醛酸和硫酸盐含量。此外,据报道,基于其在体外对聚阳离子的需求,假定的肝素特异性N - 乙酰葡糖胺N - 脱乙酰酶/N - 硫酸转移酶在体内的N - 乙酰葡糖胺N - 脱乙酰酶活性需要辅助蛋白。我们现在发现,源自胚胎牛气管的细胞(一种不合成肝素的组织)具有一种N - 乙酰葡糖胺N - 脱乙酰酶/N - 硫酸转移酶,其与上述推测参与肝素生物合成的酶具有95%的氨基酸序列同一性。这两种酶对其底物的亲和力也非常相似。气管酶在体外的N - 乙酰葡糖胺N - 脱乙酰酶活性不需要额外的效应物,尽管其生化特性与先前从产生肝素的肥大细胞瘤肿瘤细胞中分离出的酶几乎相同。由丰富的4.6千碱基mRNA编码的气管酶,与肥大细胞瘤细胞一样,与推测参与硫酸乙酰肝素生物合成的大鼠肝脏相应酶具有70%的氨基酸序列同一性。气管细胞合成的硫酸乙酰肝素比其他组织合成的硫酸乙酰肝素具有更高的硫酸化艾杜糖醛酸含量。综上所述,上述结果强烈表明,来自肥大细胞瘤、肝脏和气管的上述酶本身并非肝素或硫酸乙酰肝素选择性组织特异性合成的唯一原因;更有可能的是,细胞因子、其他酶以及高尔基体腔中底物的可用性在上述蛋白聚糖的差异合成中也起着重要作用。